Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company that focuses on improving patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company develops and commercializes the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at high risk of sudden cardiac arrest (SCA) during vulnerable recovery periods. The Cardiac Recovery System platform is centered on the ASSURE® Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also incorporates digital patient engagement and clinical workflow solutions aimed at improving patient adherence, supporting care coordination, and providing actionable clinical insights throughout the recovery process. Kestra believes the ASSURE WCD stands out due to its patient-centered design, which includes comfort, wearability, and low false alarm rates, intended to improve patient compliance during extended wear periods. Additionally, the integrated platform generates continuous cardiac rhythm data and clinically actionable insights that can assist healthcare providers in managing patients during vulnerable recovery periods. As of April 30, 2026, the ASSURE WCD has protected nearly 40,000 patients since its commercial launch.